Hartlon Vascular, Inc. is developing a drug eluting resorbable vascular scaffold (aka "stent") for the treatment of blood flow blockages in the peripheral, coronary, and cerebral arteries.
HARTLON developed a bioresorbable vascular stent that is designed to eliminate pain, non-healing sores, and risk of limb amputation caused by poor blood flow below-the-knee. After a medical doctor unblocks an artery, the patented HARTLON stent is designed to be inserted into the opening to provide temporary support until the artery heals and then the stent dissolves leaving the artery in a longer lasting natural open condition.